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Abstract
LSD1 (KDM1 under the new nomenclature) was the first identified lysine-specific histone
demethylase belonging to the flavin-dependent amine oxidase family. Here, we report that AOF1
(KDM1B under the new nomenclature), a mammalian protein related to LSD1, also possesses
histone demethylase activity with specificity for H3K4me1 and H3K4me2. Like LSD1, the highly
conserved SWIRM domain is required for its enzymatic activity. However, AOF1 differs from
LSD1 in several aspects. First, AOF1 does not appear to form stable protein complexes containing
histone deacetylases. Second, AOF1 is found to localize to chromosomes during the mitotic phase
of the cell cycle, whereas LSD1 does not. Third, AOF1 represses transcription when tethered to
DNA and this repression activity is independent of its demethylase activity. Structural and
functional analyses identified its unique N-terminal Zf-CW domain as essential for the
demethylase activity-independent repression function. Collectively, our study identifies AOF1 as
the second histone demethylase in the family of flavin-dependent amine oxidases and reveals a
demethylase-independent repression function of AOF1.
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Histone methylation is a key determinant of chromatin function, and has been shown to play
crucial roles in heterochromatin formation, X-inactivation, transcription and DNA repair [1].
Methylation of specific lysine (K) residues on histones has been linked to specific functions
such as transcriptional repression (H3K9 methylation) or activation (H3K4 methylation) [2,
3]. Histone methylation was considered to be irreversible until the identification of the first
lysine-specific histone demethylase LSD1 [4].
LSD1 is a member of the amine oxidase family of proteins and has been shown to
demethylate mono- and di-methyl K4 of histone H3 (H3K4me1 and H3K4me2) as well as
that of non-histone proteins through a FAD-dependent amine oxidation reaction [4, 5].
Biochemical studies have identified LSD1 within a number of multiprotein complexes
containing, typically, HDAC1/2 and CoREST [6–8]. Both LSD1 enzymatic activity and
substrate specificity are modulated by proteins that it interacts with. For example, CoREST
has been shown to not only potentiate LSD1 enzymatic activity but is also required for
LSD1 to demethylate nucleosomal substrates [6]. Interaction with liganded androgen
receptor has been shown to switch LSD1 enzymatic activity toward repressive H3K9
methylation [9]. Functional studies have linked LSD1 to diverse biological processes,
including transcription, DNA repair and cell cycle, possibly via its demethylase activity
toward both histone and non-histone proteins such as p53 and DNMT1 [10–12]. More
recently, a new family of proteins containing the JmjC domain was found to possess histone
demethylase activity [13]. This family of demethylases demethylates mono-, di- and tri-
methylated lysines through a hydroxylation reaction that requires Fe(II) and α-ketoglutarate
as cofactors. Due to the intrinsic difference in the underlying mechanism of demethylation
(oxidation vs hydroxylation), LSD1 can theoretically demethylate only mono-and di-
methylated lysine residues [14], whereas the JmjC family of demethylases can also act on
tri-methylated lysines [15, 16]. So far a large number of histone demethylases have been
identified from the JmjC domain-containing family of proteins [17–20].
Among the amine oxidase proteins, AOF1 is highly related to LSD1 in both sequence and
structure [4]. Like LSD1, AOF1 also contains a SWIRM domain and a C-terminal oxidase
domain (see Figure 1). AOF1 differs from LSD1 in containing a unique N-terminal Zf-CW
domain. The Zf-CW domain is a type of four-cysteine zinc-finger motif named for its
conserved cysteine and tryptophan residues [21]. Here, we report that mouse AOF1 also
possesses a histone demethylase activity specific for H3K4me1 and H3K4me2. We show
that AOF1 differs from LSD1 in association with HDAC and mitotic chromosomes, and
may regulate transcription in a demethylase activity-independent manner through its unique
Zf-CW domain.
Results
AOF1 exhibits an H3K4-specific demethylase activity in vitro
Given the sequence and structural similarity between AOF1 and LSD1 (Figure 1A), we were
interested in determining if AOF1 is also a histone demethylase. Toward this end, we
expressed both human LSD1 and mouse AOF1 from baculovirus-infected Sf9 insect cells.
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His-tagged AOF1 was purified to near homogeneity via nickel-based affinity purification,
whereas LSD1 was purified via Flag-tag using anti-Flag-M2 agarose beads (Figure 1B). For
demethylation assays, we made use of the site-specificity of histone methyltransferases
SET7, G9a, vSET and EZH2 and 3H-SAM (S-adenosyl-[methyl-3H]-L-methionine) to
generate radiolabeled core histone substrates, methylated specifically at the K4, K9 or K27
site of histone H3, as described previously [13]. When these substrates were subjected to
demethylation assay using increasing amounts of recombinant AOF1 or LSD1, we found
that, like LSD1, AOF1 also exhibited an H3K4-specific demethylase activity and displayed
no activity toward K9- or K27-methylated H3 substrates. In multiple experiments, we found
that after normalizing the protein concentrations, the demethylase activity of AOF1 is
somewhat lower than that of LSD1. Given that SET7 generated H3K4me1 and H3K4me2,
this result indicates that AOF1 has a histone demethylase activity toward H3K4me1 and
H3K4me2.
AOF1 exhibits an H3K4-specific demethylase activity in cells
To further substantiate the H3K4 demethylase activity of AOF1, we expressed mouse AOF1
as Flag-tagged proteins in HeLa cells and examined the demethylase activity by measuring
the levels of H3K4me1 and H3K4me2 by immunofluorescence. In agreement with the in
vitro demethylation assay results, the representative results in Figure 2B show that the cells
expressing Flag-AOF1 had reduced levels of H3K4me1 and H3K4me2 in comparison to
neighboring cells that did not express Flag-AOF1. Also consistent with the in vitro
demethylation data, no demethylase activity toward H3K9 and H3K27 was observed for
AOF1 (Supplementary information, Figure S1). Consistent with the chemistry of a FAD-
dependent amine oxidation reaction, no H3K4me3 demethylase activity was detected for
AOF1 (Supplementary information, Figure S2). It is noteworthy that in this assay, AOF1 in
general exhibited a better H3K4me2 demethylase activity than LSD1. While a clear
reduction of H3K4me2 could be observed for transfected cells expressing Flag-LSD1
(Figure 2B), we often did not observe a significant reduction for H3K4me1 (data not
shown). The strong demethylase activity observed for ectopically expressed AOF1 in HeLa
cells is in contrary to the in vitro demethylase assay data in Figure 1, in which LSD1
exhibited a higher activity than AOF1. Although this discrepancy is currently not
understood, one possibility is that the demethylase activity of AOF1 was enhanced by one or
more proteins in HeLa cells. The purified recombinant AOF1 might lack this protein(s) and
therefore its demethylase activity was compromised.
Previous studies on LSD1 indicate that K661 in the amine oxidase domain is required for its
demethylase activity, presumably because it is required for binding of cofactor FAD [22,
23]. Sequence comparison with LSD1 revealed a conserved K667 in AOF1. We thus
converted this residue to alanine (referred as AOF1m) and tested the effect on the enzymatic
activity. We found that this mutation impaired the AOF1 demethylase activity, implying that
binding of FAD is indeed essential for AOF1 demethylase activity. Taken together, we
conclude that like LSD1, AOF1 also has a FAD-dependent demethylase activity toward
H3K4me1 and H3K4me2.
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Both Zf-CW and SWIRM domains are required for AOF1 demethylase activity
As shown in Figure 1A, AOF1 contains a unique Zf-CW domain and a SWIRM domain that
is also present in LSD1. The SWIRM domain is present in several proteins involved in
chromatin remodeling [24, 25]. The SWIRM domain has been shown to be required for
LSD1 demethylase activity and forms a compact structure with the amine oxidase domain
[22, 26]. We thus attempted to test if the SWIRM domain in AOF1 is also required for
AOF1 demethylase activity. We constructed the AOF1Δ381 mutant with deletion of both
SWIRM and Zf-CW domains and the AOF1Δ271 mutant with the deletion of Zf-CW
domain only. These mutants were transfected into HeLa cells and tested for demethylase
activity toward H3K4me1 or H3K4me2. The results in Figure 2B show that the AOF1Δ381
mutant exhibits no demethylase activity toward H3K4me1 and H3K4me2. Interestingly, we
found that the AOF1Δ271 mutant with an intact SWIRM and amine oxidase domain also has
no demethylase activity. One potential explanation for this result is the altered subcellular
localization of AOF1Δ271 mutant. We observed that in ~80% Flag-AOF1Δ271- expressing
cells Flag-AOF1Δ271 was mainly present in the cytoplasm. However, there were ~10–20%
cells in which a nuclear presence of Flag-AOF1Δ271 was observed (Figure 2B), yet
demethylation of H3K4me1 and H3K4me2 was not observed within these cells.
To further test the requirement of Zf-CW and SWIRM domain for AOF1 demethylase
activity, we constructed two additional mutants, AOF1Δ147–150 and AOF1Δ372–382. The
AOF1Δ147–150 mutant contains a deletion of four conserved amino acids within the Zf-CW
domain, whereas the AOF1Δ372–382 mutant has a deletion of 11 amino acids within the
conserved SWIRM domain. When tested for demethylase activity by immunofluorescence
(Figure 2B), we found that both mutants were inactive for demethylation of H3K4me1 and
H3K4me2. These results indicate that both the Zf-CW and SWIRM domains are required for
optimal H3K4 demethylase activity of AOF1.
AOF1 associates with mitotic chromosomes
From the above immunofluorescent experiments, we observed that within mitotic cells, the
majority of AOF1 proteins localized to mitotic chromosomes (Figure 3A). This chromosome
localization in mitotic cells is independent of the AOF1 demethylase activity, since the
AOF1m mutant defective of the enzymatic activity was also chromosome associated (Figure
3B). This result prompted us to test if LSD1 also localizes to the mitotic chromosomes. As
shown in Figure 3C, the chromosome association in mitotic cells was not observed for
LSD1. Interestingly, we found that the AOF1 chromosome association required its unique
N-terminal Zf-CW domain, as the chromosome association was not observed for the
AOF1Δ271 mutant (Figure 3D). This result indicates that LSD1 and AOF1 differ in the
association with mitotic chromosomes and suggests that the unique Zf-CW domain is likely
responsible for targeting AOF1 to mitotic chromosomes.
AOF1 does not appear to form stable protein complex with histone deacetylases
LSD1 has been identified in several multiprotein complexes containing HDAC1/2 and
HDAC3 [6–8]. To investigate if AOF1 also similarly forms protein complexes with histone
deacetylases, we next carried out co-immunoprecipitation assays using HeLa nuclear
extracts (Figure 4A). Consistent with previous reports, a substantial amount of HDAC1/2
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was found to co-immunoprecipitate with LSD1 by western blot analysis using an antibody
that can immunoprecipitate HDAC1, but detect both HDAC1 and HDAC2 (the band marked
by an arrow) in western blot. Similarly, LSD1 was found to co-immunoprecipitate with
HDAC1 and HDAC3. In contrast, HDAC1/2 was not detected in the AOF1-
immunoprecipitated fraction and AOF1 was not detected in the fraction immunoprecipitated
with either HDAC1 or HDAC3 antibody, indicating that in HeLa nuclear extracts, AOF1
was not associated with HDAC1/2 and HDAC3.
To further examine if AOF1 associates with HDAC1/2, we generated a HeLa cell line stably
expressing Flag-AOF1. The Flag-AOF1 was isolated from the whole cellular extracts using
anti-Flag-M2 agarose beads. As a control, LSD1 was also immunoprecipitated using LSD1
antibody. The subsequent western analysis again revealed co-immunoprecipitation of
HDAC1/2 with LSD1, but not with Flag-AOF1, thus confirming that AOF1 is not physically
associated with HDAC1/2 (Figure 4B).
While the above results exclude the association of AOF1 with HDAC1/2, it remains a
possibility that AOF1 associates with other HDACs. To test this, we subjected the
immunopurified Flag-AOF1 and LSD1, as described above, to a fluorometric in vitro
HDAC activity assay [27]. TSA, an HDAC inhibitor, was included to determine if the
associated HDAC activity was derived from TSA-sensitive class I and class II HDACs. A
representative result shown in Figure 4C demonstrates that, while a substantial TSA-
sensitive HDAC activity is associated with LSD1, the HDAC activity associated with AOF1
was at the background level. Taken together, our results indicate that AOF1 is unlikely to
form stable protein complex(es) containing histone deacetylases.
AOF1 has a histone demethylase-independent repression activity
Having established AOF1 as an H3K4 demethylase, we next wished to examine the
potential role of AOF1 in transcription. As an H3K4 demethylase, AOF1 is expected to
remove the active transcriptional marker and therefore confers transcriptional repression.
Consistently, previous study has shown that when targeted to a transcriptional reporter as a
Gal4(DBD) (DNA-binding domain) fusion protein, LSD1 functions as a repressor and this
repression activity is to a certain extent dependent on its demethylase activity [4]. Using the
same approach, we found that Gal-AOF1 repressed transcription from a 4×UAS-TK-luc
reporter (Figure 5B). Surprisingly, we found that the enzymatically defective AOF1 K667A
mutant (Gal-AOF1m) repressed transcription as effectively as the wild-type AOF1. The
expression of both Gal-AOF1 and Gal-AOF1m was confirmed by western blotting (Figure
5A). Thus, unlike LSD1, AOF1 appears to have a histone demethylase activity-independent
repression function.
To test if the observed demethylase-independent repression may derive from recruitment of
histone deacetylases, we repeated the above experiments with addition of the histone
deacetylase inhibitor TSA. The results in Figure 5B lower panel show that addition of TSA
resulted in an overall increase of transcriptional activity from the luciferase reporter, but did
not significantly affect the repression by both Gal-AOF1 and Gal-AOF1m. This result
excludes recruitment of class I and class II HDACs as a mechanism for AOF1 demethylase-
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independent repression and is consistent with the biochemical data that AOF1 is not
associated with histone deacetylases.
The unique Zf-CW domain is required for AOF1 transcriptional repression activity
Previous studies indicate that reporter DNA introduced into the nuclei of Xenopus oocytes
through microinjection will be assembled into chromatin [28], presumably as a result of
abundant chromatin assembly activities and core histone proteins in Xenopus oocytes.
Xenopus oo-cytes are also ideal for expression of exogenous proteins by microinjection of
corresponding in vitro synthesized mRNAs [29]. Xenopus oocytes therefore have been
extensively used as a convenient model for transcriptional analysis in the context of
chromatin [30, 31]. Using an experimental scheme illustrated in Figure 6A, we expressed
AOF1 as a Gal4 DBD fusion protein in Xenopus oocytes and tested its ability to repress
transcription from three different transcription reporters. We found that expression of Gal-
AOF1 led to repression of all three reporters, as revealed by primer extension analysis
(Figure 6B-6D). The primer extension reactions also included a primer specific for Xenopus
storage histone H4 mRNA, and the resulting product (cx) served as an internal loading
control. As a control, expression of Gal-LSD1 also resulted in repression of all three
reporters.
Having demonstrated that AOF1 broadly repressed transcription in Xenopus oocytes, we
next wished to determine if the demethylase activity is required for repression and if not, the
region responsible for the observed transcriptional repression activity. For this purpose, a
new set of AOF1 deletion mutants suitable for Xenopus oocyte expression was generated
(Figure 7A). A representative result in Figure 7C shows that the demethylasedefective Gal-
AOF1m (K667A) repressed transcription as effectively as Gal-AOF1 did, indicating that the
repression is again demethylase activity independent. However, deletion of the N-terminal
Zf-CW alone or both ZF-CW and SWIRM domains resulted in loss of repression. On the
other hand, deletion of the C-terminal amine oxidase domain has no effect on repression.
Western blot analysis showed that all these AOF1 proteins were expressed to a similar level
as revealed by using an anti-Gal4 (DBD) antibody (Figure 7B). Together, these results
further substantiate an H3K4 demethylase activity-independent repression function for
AOF1 and identify the unique Zf-CW domain as a key determinant for repression.
Discussion
AOF1 exhibits H3K4 histone demethylase activity
Among the mammalian amine oxidase family proteins, AOF1 is highly related to LSD1 and
was predicted to be a nuclear protein. In this study, we tested if like LSD1, AOF1 also
possesses a histone demethylase activity. Using recombinant mouse AOF1 expressed and
purified from SF9 insect cells and radiolabeled core histone substrates, we detected a
demethylase activity toward H3K4me1 and H3K4me2 (Figure 1). Under our experimental
conditions, no demethylase activity toward H3K9 and H3K27 was detected for AOF1. This
result is in agreement with the work from Andrea Mattevi’s laboratory that was published
during the preparation of our manuscript [32]. However, given that both the enzymatic
specificity and activity of LSD1 demethylase have been reported to be modulated by the
Yang et al. Page 6






















proteins that it interacts [6, 9], we also expressed AOF1 in HeLa or NIH3T3 cells and
analyzed its histone demethylase activity by immunofluorescence using various antibodies
against methylated histone H3. Using this approach, we again found that AOF1 has a
demethylase activity toward H3K4me1 and H3K4me2, and has no demethylase activity
toward H3K9, H3K27 and H3K36 methylation. Consistent with the notion that amine
oxidation reaction can only lead to demethylation of mono- and di-methylated lysine
residues, no demethylase activity toward H3K4me3 was detected for AOF1. Thus, in
agreement with a recent work from Taiping Chen and coworkers [33], both in vitro and in
vivo data indicate that AOF1 is an H3K4-specific his-tone demethylase.
Given the sequence and structural similarity between AOF1 and LSD1, it is not surprising
that mutation of a conserved histidine residue (K667A) in the oxidase domain impairs AOF1
demethylase activity. Previous studies indicated that the SWIRM domain is required for
LSD1 demethylase activity [22, 26]. Similarly, we found that deletion of a stretch of 11
conserved amino acids within the AOF1 SWIRM domain impairs its enzymatic activity.
Interestingly, we found that deletion of either the entire N-terminal unique Zf-CW domain
or just four amino acids within the Zf-CW domain (AOF1Δ147–150) also impairs AOF1
demethylase activity. The Zf-CW domain is predicted to be a highly specialized four-
cysteine zinc-finger that plays a role in DNA binding and/or promoting protein-protein
interactions. Although it is not clear why deletion of Zf-CW domain impairs AOF1
demethylase activity, Zf-CW domain is present in a dozen of proteins that have been
implicated in the regulation of chromatin methylation status and early embryonic
development.
In this study, we also find that AOF1 is associated with mitotic chromosomes, whereas
LSD1 is not. The Zf-CW domain is required for chromosome association, as the AOF1Δ271
mutant was not associated with mitotic chromosomes. The mitotic chromosome association
suggests that AOF1 may play a role in epigenetic inheritance of H3K4 methylation during
cell divisions. In this regard, AOF1 was very recently reported to be required for
establishing maternal genomic imprints [33]. It is thus tempting to suggest that its
chromosome association may be related to its crucial role in regulating maternal genomic
imprinting. Future study is thus needed to determine the functional significance of AOF1
mitotic chromosome association.
AOF1 does not appear to form an HDAC-containing protein complex
Our preliminary gel filtration analysis suggests that AOF1 in HeLa cells is likely to exist in
a large protein complex (Yang and Wong, unpublished data ). However, unlike LSD1, our
extensive immunoprecipitation and HDAC activity assays suggest that AOF1 does not
appear to associate with HDAC1/2 or other class I and class II HDACs. This result is in
agreement with and is an expansion of the work from Andrea Mattevi’s laboratory [32]. This
difference in HDAC association may be explained by the lack of Tower domain in AOF1.
The Tower domain in LSD1 is required for its interaction with CoREST and MTA1 and,
therefore, the association with HDAC1/2 [23, 26]. The lack of HDAC association is also
consistent with the observed TSA-insensitive repression by AOF1 in tethering experiments
(Figure 5B).
Yang et al. Page 7






















The unique Zf-CW domain of AOF1 confers histone demethylase-independent repression
function
A novel finding in this study is that AOF1 has a demethylase activity-independent
repression activity, and this activity is dependent on its unique Zf-CW domain. LSD1 has
been shown to repress transcription when tethered to a reporter as a Gal4 fusion protein [4].
This repression function is compromised for the LSD1 mutant defective in demethylase
activity. To our surprise, we found that the enzymatically defective AOF1 H667A mutant
represses transcription as effectively as the wild-type AOF1, both in mammalian cells and in
Xenopus oocytes, suggesting that AOF1 differs from LSD1 and possesses a demethylase
activity-independent repression function. Given that the AOF1 repression activity is
insensitive to TSA and that AOF1 does not appear to associate with substantial HDAC
activity, we conclude that this demethylase-independent repression activity is likely also
HDAC independent. Further structural and functional analyses identified the N-terminal Zf-
CW domain as essential for repression function. Although the Zf-CW domain is unique for
AOF1, sequence comparison reveals it is conserved among AOF1 proteins from different
organisms. Given that the Zf-CW domain is required for both mitotic chromosome
association and repression function, it raises the question as to whether the role of AOF1 in
maternal imprinting is entirely H3K4 demethylase activity dependent. Future work is
required to determine the underlying mechanism of AOF1 Zf-CW domain-mediated
repression and its biological function.
Materials and Methods
Plasmids, antibody, cell culture and stable cell line
To express AOF1 in SF9 cells, the full-length open reading frame of mouse AOF1 cDNA
(MGC:38211) was PCR amplified, digested with SalI and XbaI and cloned into
pFastBacHTC vector also digested with SalI and XbaI. In addition, the full-length AOF1
was PCR amplified, digested with HindIII and NheI and cloned into a modified
pcDNA5/FRT/TO vector also digested with HindIII and NheI. The sequence of AOF1 was
verified by sequencing. The AOF1m (K667A) was generated using site-directed
mutagenesis. The AOF1 mutants with deletion of N-terminal 271 amino acids (AOF1Δ271)
or 381 amino acids (AOF1Δ381) were generated by PCR-based cloning, as described above,
and verified by sequencing. The mutants with a small deletion in either the Zf-CW domain
(AOF1Δ147–150) or SWIRM domain (AOF1Δ372–382) were generated using PCR-based
site-directed mutagenesis and verified by DNA sequencing. To express AOF1 and AOF1m
as a Gal4-DBD fusion protein, the corresponding DNA fragments were cleaved from
pcDNA5/FRT/TO vector and cloned into pCMX-Gal vector. To express AOF1 and various
mutants in Xenopus oocytes, the corresponding DNA fragments were cloned into a modified
pSP64-poly(A) vector. Three reporters (4×UAS-TRβA-CAT, 4×UAS-TK-CAT and 4×UAS-
AdML-CAT) used for transcriptional analysis in Xenopus oocytes were obtained as
described [34].
Antibodies against H3K4me1, H3K4me2, H3K9me1, H3K9me2 and H3K27me2 were
purchased from Abcam (Cambridge, MA, USA). The H3K36me2 antibody was a gift from
professor Degui Chen (Shanghai Institute of Biochemistry and Cell Biology, Shanghai,
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China). Gal4 (DBD) antibody was purchased from Santa Cruz Biotechnology (Santa Cruz,
CA, USA). Flag-tag (M2) antibodies were purchased from Sigma (St Louis, MO, USA).
Rabbit polyclonal anti-HDAC1 antibody was a kind gift from Dr Jiangou Song (Shanghai
Institute of Biochemistry and Cell Biology, Shanghai, China). The mouse polyclonal AOF1
antibody was from AbMart (Shanghai, China) and monoclonal LSD1 antibody was
purchased from Nexus Biological (Houston, TX, USA).
HeLa cells were maintained in DMEM medium (Hyclone) supplemented with 10% fetal
bovine serum and 100 U penicillin-streptomycin. The stable Flag-AOF1 expressing HeLa
cell line was established by transfecting HeLa cells with pcDNA5-FRT/ TO-AOF1 and
followed by selection with 150 µg/ml hygromycin B for 2 weeks.
Preparation of recombinant AOF1 and LSD1
Recombinant AOF1 was expressed as His-tagged proteins in SF9 cells using the Bac-to-Bac
baculoviral system (Invitrogen). The recombinant Flag-LSD1 was expressed and purified
from SF9 cells as described [17].
In vitro demethylation assay
The histone demethylase assay was performed essentially as previously described [17].
Briefly, various 3H-SAM-labeled histone substrates were incubated with recombinant Flag-
AOF1 or FLAG-LSD 1 in histone demethylation buffer (100 mM glycine (pH 9) or 1 mM
PMSF or 1 mM DTT or 50 mM KCl) at 37 °C for 1 h. For detection of the released 3H-
formaldehyde, a modified NASH method was used. After trichloroacetic acid precipitation,
an equal volume of NASH reagent (3.89 M ammonium acetate, 0.1 M acetic acid and 0.2%
2,4-pentanedione) was added into the supernatant, and the mixtures were incubated at 37 °C
for 50 min before extraction with equal volume of 1-pentanol. The extracted radioactivity
was measured by scintillation counting.
Immunoprecipitation and western blotting
To prepare whole cell extracts from stable Flag-AOF1 HeLa cells, the cells from ten 10-cm
plates were washed with phosphatebuffered saline (PBS) two times and lysed with ice-cold
EBC buffer (20 mM Tris-HCl (pH 8.0), 125 mM NaCl, 2 mM EDTA and 0.5% NP-40) with
protease inhibitors for 15 min. The lysate was centrifuged at 13 000× g for 15 min at 4 °C to
remove cell debris. Immunoprecipitation was performed with 100 µl whole cell extract and
anti-Flag-M2 beads or LSD1 antibody. Western blot analysis was performed using
antibodies as described. Primary antibodies were diluted in the ratio of 1:1 000, except for
anti-Gal4 (DBD) and anti-Flag, which were diluted in the ratio of 1:5 000.
For western blot analysis using Xenopus oocyte, whole cell extracts and 5 to 10 oocytes
were homogenized in 100 mM Tris/10 mM EDTA (pH 8.0) (10 µl per oocyte) and
centrifuged to remove insoluble material. Western blot analyses were performed as
previously described [34].
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For detecting AOF1 demethylase activity by immunofluorescent staining, HeLa cells were
transfected with the wild-type or mutant AOF1 in pcDNA5-FRT/TO vector using
lipofectamine 2000 (Invitrogen) according to manufacturers instruction. At 48 h after
transfection, the cells were fixed with 4% paraformaldehyde, permeabilized in 1% Trition
X-100/PBS and then processed for immunofluorescent staining as described [17]. DNA was
stained with Hochester 33342 stain. Primary antibodies were used at the following dilution:
1:250 for H3K4me1, H3K9me2, H3K27me2, H3K36me2; 1:500 for H3K4me3; 1:1 000 for
H3K4me2 and 1:3 000 for anti-Flag (Sigma). Secondary goat-anti-rabbit (Alexa fluor 555)
and goat-anti-mouse (Alexa fluor 488) were purchased from Molecular Probes and used at
1:500 dilution.
Dual-reporter luciferase activity assay
Transfection for luciferase activity assay was performed in 24-well plates using
lipofectamine 2000 (Invitrogen). The Gal4DBD-AOF1 and Gal4DBD-AOF1 mutant
plasmids were co-transfected with 4×UAS-TK-firefly luciferase plasmid and a control
Renilla luciferase plasmid, which is under control of the thymidine kinase (TK) promoter.
Luciferase activity in the cell lysates was determined by using a dual luciferase reporter
assay system (Promega, WI, USA) 48 h post-transfection and the luciferase activity was
normalized to the TK Renilla activity. Treatments with 50 nM trichostatin A was performed
for 12 h before the cells were harvested for luciferase assay.
In vitro HDAC assay
To measure HDAC activity associated with AOF1, whole cell extracts were prepared from
the stable Flag-AOF1 HeLa cells. Flag-AOF1 was immunoprecipitated with Flag-M2 beads
(Sigma). As controls, the whole cell extracts were also immunoprecipitated with protein G
alone (mock) or with protein G plus LSD1 antibody. After extensive washes, the resulting
beads were subjected to HDAC activity assays using a histone deacetylase assay kit from
Sigma (catalog number cs1010) according to manufacturers instruction. The excited
fluorophore resulting from HDAC reactions was detected on a multi-detection microplater
reader (Tecan M200).
Microinjection of Xenopus oocytes
Preparation and microinjection of mRNA and reporter DNA into stage VI Xenopus oocytes
were performed as previously described [34]. All capped poly-A mRNAs used for injection
were synthesized using a SP6 mESSAGE mACHINE kit (Ambion, Austin, TX, USA).
mRNA was injected at a concentration of 100 ng/µl (18.4 nl per oocyte) and reporter DNA
was injected at a concentration of 50 ng/µl (18.4 nl per oocyte) according to the
experimental scheme described in each figure.
Primer extension analysis
Primer extension was used to analyze the RNA transcripts produced from reporter genes
injected into Xenopus oocytes. The primer for all three reporters (4×UAS-TRβA-CAT,
4×UAS-TK-CAT and 4×UAS-AdML-CAT) is 5′-GTG AAG GAT AAG TGA CGA GCG
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GAG ACG-3′. The procedure used for primer extension has been previously described [35].
The Xenopus oocyte storage histone H3 mRNA was used as an internal control in all primer
extension assays [35]. Each experiment was repeated at least twice.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Recombinant AOF1 acts as an H3K4 demethylase in vitro. (A) Diagram illustrating the
similarity and difference in domain organization of AOF1 and LSD1. Note that AOF1
contains a unique Zf-CW (CW-type Zinc-Finger) domain and lacks a Tower domain that has
been shown to mediate the interaction of LSD1 with the corepressor CoREST. (B)
Recombinant AOF1 and LSD1 were expressed and purified from SF9 insect cells via His-
and Flag-tag, respectively. The increasing amounts of AOF1 and LSD1 used in demethylase
activity assays were revealed by Coomassie blue staining. Histone demethylase assays were
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performed using core histones substrates containing 3H-methyl-H3K4 (C), H3K9 (D) or
H3K27 (E), respectively, and an increasing amount of AOF1 or LSD1 proteins. The
demethylase activity was measured based on the release of radioactivities from labeled core
histone or oligonucleosome substrates, as indicated.
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AOF1 acts as a mono- and di-H3K4 demethylase in cells. (A) Diagram showing point and
deletion mutants of AOF1. (B) Flag-tagged AOF1 and its mutants were transfected into
HeLa cells and the demethylase activity was detected by immunofuorescence using various
methylated H3-specifc antibodies. LSD1 served as a positive control for H3K4me2
demethylase activity. Arrows mark the cells in which the proteins of interest were expressed.
Note that reduced levels of H3K4me1 and H3K4me2 were observed in cells expressing the
wild-type Flag-AOF1 but not in cells expressing AOF1 K667A mutant and deletion mutants.
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AOF1 associates with mitotic chromosomes during the M phase of cell cycle. Flag-AOF1
(A), Flag-AOF1m (B), Flag-AOF1Δ271 (C) and Flag-LSD1 (D) were transfected into HeLa
cells and a representative pattern of subcellular localization in the M phase cells was shown.
Note that both Flag-AOF1 and Flag-AOF1m colocalized with DAPI-stained mitotic
chromosomes, whereas Flag-AOF1Δ271 and Flag-LSD1 were absent in the mitotic
chromosomes.
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AOF1 differs from LSD1 in association with histone deacetylases. (A) HeLa nuclear
extracts were immunoprecipitated with antibodies against HDAC1, HDAC3, AOF1 or
LSD1, and blotted with antibodies indicated. Input 10% of extracts for IP. Note that HDAC1
antibody detected both HDAC1 and HDAC2 (marked with an arrow). (B) A stable Flag-
AOF1 HeLa cell line was established and IP-western blot analysis was performed using
whole cell extracts derived from this stable cell line. Input, 10% of whole cell extracts for
IP. (C) Relative HDAC activity associated with LSD1 and AOF1. The whole cell extracts
derived from Flag-AOF1-stable cells were first immunoprecipitated with protein G beads
(mock), LSD1 antibody + protein G beads or anti-Flag M2 beads, and then subjected to a
fluorometric-based HDAC activity assay. The final concentration of TSA is 1.25 µM.
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AOF1 possesses a demethylase- and HDAC-independent repression activity. (A) Plasmids
encoding a Gal4(DBD) fusion of AOF1 or AOF1 H667A mutant were transfected into HeLa
cells and the expression was detected by western blotting using a Gal4(DBD)-specifc
antibody. (B) HeLa cells were transfected with Gal-AOF1 or Gal-AOF1m (K667A) mutant
together with a luciferase reporter (4×UAS-TK-luc) and treated with or without addition of
330 nM TSA. Amounts of plasmids used: 100 ng for 4×UAS-TK-luc, 75 ng and 150 ng for
Gal-AOF1 and Gal-AOF1m. Note that addition of TSA resulted in an overall increase in
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luciferase activity, but had no significant effect on repression by both wild type and mutant
AOF1. The relative luciferase activities are the mean ± SEM of three independent
transfections.
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In Xenopus oocytes, both LSD1 and AOF1 exhibit a broad repression activity. (A) Diagram
illustrating the experimental procedure, including microinjection of mRNA encoding Gal-
AOF1 or Gal-LSD1 into the cytoplasm and reporter DNA into nuclei. After overnight
incubation, total RNAs were prepared from injected oocytes and primer extension was
performed to measure transcripts derived from the reporters. (B) Primer extension analysis
revealed that expression of Gal-LSD1 and Gal-AOF1 repressed transcription from Xenopus
TRβA promoter. Expt, the primer extension product from 4×UAS-TRβA-CAT; Cx, primer
extension product from endogenous storage histone H4 mRNA that served as an internal
control. (C) Expression of Gal-LSD1 and Gal-AOF1 repressed transcription from 4×UAS-
TK-CAT reporter. (D) Expression of Gal-LSD1 and Gal-AOF1 repressed transcription from
4×UAS-AdML-CAT reporter.
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The unique Zf-CW domain is required for AOF1 demethylase-independent repression
activity. (A) Diagram illustrating the structure of new set of AOF1 mutants for Xenopus
oocyte expression. (B) The in vitro synthesized mRNAs encoding Gal-AOF1 and various
mutants were injected into groups of Xenopus oocytes that were also injected with 4×UAS-
TK-CAT reporter and the expression was detected by western blot analysis. (C) The total
RNAs derived from the same groups of Xenopus oocytes as in (B) were analyzed by primer
extension. Note that disruption of the N-terminal unique Zf-CW domain (Gal-AOF1Δ163)
abolishes the AOF1 repression activity, indicating that the Zf-CW domain is required for
repression.
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